Savings through generic drug usage in the U.S., by payer 2022
This statistic depicts savings through generic drugs and biosimilars usage in the United States in 2022, by payer. In that year, Medicare Part D and Medicaid health program saved around 131 and 65 billion U.S. dollars through generics, respectively.